BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35055004)

  • 1. Schwannoma Gene Therapy via Adeno-Associated Viral Vector Delivery of Apoptosis-Associated Speck-like Protein Containing CARD (ASC): Preclinical Efficacy and Safety.
    Ahmed SG; Maguire CA; Cao SA; Brenner GJ
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy with apoptosis-associated speck-like protein, a newly described schwannoma tumor suppressor, inhibits schwannoma growth in vivo.
    Ahmed SG; Abdelnabi A; Maguire CA; Doha M; Sagers JE; Lewis RM; Muzikansky A; Giovannini M; Stemmer-Rachamimov A; Stankovic KM; Fulci G; Brenner GJ
    Neuro Oncol; 2019 Jul; 21(7):854-866. PubMed ID: 30977509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schwannoma gene therapy by adeno-associated virus delivery of the pore-forming protein Gasdermin-D.
    Ahmed SG; Abdelanabi A; Doha M; Brenner GJ
    Cancer Gene Ther; 2019 Sep; 26(9-10):259-267. PubMed ID: 30622323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of schwannomas induced by adeno-associated virus-mediated delivery of caspase-1.
    Prabhakar S; Taherian M; Gianni D; Conlon TJ; Fulci G; Brockmann J; Stemmer-Rachamimov A; Sena-Esteves M; Breakefield XO; Brenner GJ
    Hum Gene Ther; 2013 Feb; 24(2):152-62. PubMed ID: 23140466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging and therapy of experimental schwannomas using HSV amplicon vector-encoding apoptotic protein under Schwann cell promoter.
    Prabhakar S; Brenner GJ; Sung B; Messerli SM; Mao J; Sena-Esteves M; Stemmer-Rachamimov A; Tannous B; Breakefield XO
    Cancer Gene Ther; 2010 Apr; 17(4):266-74. PubMed ID: 19834516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing myelin specific promoters for schwannoma gene therapy.
    Ahmed SG; Hadaegh F; Brenner GJ
    J Neurosci Methods; 2019 Jul; 323():77-81. PubMed ID: 31125589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful Repeated Hepatic Gene Delivery in Mice and Non-human Primates Achieved by Sequential Administration of AAV5
    Majowicz A; Salas D; Zabaleta N; Rodríguez-Garcia E; González-Aseguinolaza G; Petry H; Ferreira V
    Mol Ther; 2017 Aug; 25(8):1831-1842. PubMed ID: 28596114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of primitive murine hematopoietic stem and progenitor cell transduction in vitro and in vivo by recombinant adeno-associated virus vector serotypes 1 through 5.
    Zhong L; Li W; Li Y; Zhao W; Wu J; Li B; Maina N; Bischof D; Qing K; Weigel-Kelley KA; Zolotukhin I; Warrington KH; Li X; Slayton WB; Yoder MC; Srivastava A
    Hum Gene Ther; 2006 Mar; 17(3):321-33. PubMed ID: 16544981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of viral dose on neutralizing antibody response and transgene expression after AAV1 vector re-administration in mice.
    Petry H; Brooks A; Orme A; Wang P; Liu P; Xie J; Kretschmer P; Qian HS; Hermiston TW; Harkins RN
    Gene Ther; 2008 Jan; 15(1):54-60. PubMed ID: 17960164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safe and stable noninvasive focal gene delivery to the mammalian brain following focused ultrasound.
    Stavarache MA; Petersen N; Jurgens EM; Milstein ER; Rosenfeld ZB; Ballon DJ; Kaplitt MG
    J Neurosurg; 2018 Apr; 130(3):989-998. PubMed ID: 29701544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraventricular brain injection of adeno-associated virus type 1 (AAV1) in neonatal mice results in complementary patterns of neuronal transduction to AAV2 and total long-term correction of storage lesions in the brains of beta-glucuronidase-deficient mice.
    Passini MA; Watson DJ; Vite CH; Landsburg DJ; Feigenbaum AL; Wolfe JH
    J Virol; 2003 Jun; 77(12):7034-40. PubMed ID: 12768022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rescue of Hearing by Gene Delivery to Inner-Ear Hair Cells Using Exosome-Associated AAV.
    György B; Sage C; Indzhykulian AA; Scheffer DI; Brisson AR; Tan S; Wu X; Volak A; Mu D; Tamvakologos PI; Li Y; Fitzpatrick Z; Ericsson M; Breakefield XO; Corey DP; Maguire CA
    Mol Ther; 2017 Feb; 25(2):379-391. PubMed ID: 28082074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy with the caspase activation and recruitment domain reduces the ocular inflammatory response.
    Ildefonso CJ; Jaime H; Biswal MR; Boye SE; Li Q; Hauswirth WW; Lewin AS
    Mol Ther; 2015 May; 23(5):875-884. PubMed ID: 25698151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular Inflammatory Response to Intravitreal Injection of Adeno-Associated Virus Vector: Relative Contribution of Genome and Capsid.
    Timmers AM; Newmark JA; Turunen HT; Farivar T; Liu J; Song C; Ye GJ; Pennock S; Gaskin C; Knop DR; Shearman MS
    Hum Gene Ther; 2020 Jan; 31(1-2):80-89. PubMed ID: 31544533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene Delivery of Activated Factor VII Using Alternative Adeno-Associated Virus Serotype Improves Hemostasis in Hemophiliac Mice with FVIII Inhibitors and Adeno-Associated Virus Neutralizing Antibodies.
    Sun J; Hua B; Chen X; Samulski RJ; Li C
    Hum Gene Ther; 2017 Aug; 28(8):654-666. PubMed ID: 28478688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice.
    Liguore WA; Domire JS; Button D; Wang Y; Dufour BD; Srinivasan S; McBride JL
    Mol Ther; 2019 Nov; 27(11):2018-2037. PubMed ID: 31420242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Preclinical Study in Rhesus Macaques for Cystic Fibrosis to Assess Gene Transfer and Transduction by AAV1 and AAV5 with a Dual-Luciferase Reporter System.
    Guggino WB; Benson J; Seagrave J; Yan Z; Engelhardt J; Gao G; Conlon TJ; Cebotaru L
    Hum Gene Ther Clin Dev; 2017 Sep; 28(3):145-156. PubMed ID: 28726496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.
    Janelidze S; Nordström U; Kügler S; Brundin P
    J Gene Med; 2014; 16(9-10):300-8. PubMed ID: 25303717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AAV-Mediated Gene Delivery to the Spinal Cord by Intrathecal Injection.
    Peterson CD; Skorput AGJ; Kitto KF; Wilcox GL; Vulchanova L; Fairbanks CA
    Methods Mol Biol; 2019; 1950():199-207. PubMed ID: 30783975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safe and Sustained Expression of Human Iduronidase After Intrathecal Administration of Adeno-Associated Virus Serotype 9 in Infant Rhesus Monkeys.
    Hordeaux J; Hinderer C; Buza EL; Louboutin JP; Jahan T; Bell P; Chichester JA; Tarantal AF; Wilson JM
    Hum Gene Ther; 2019 Aug; 30(8):957-966. PubMed ID: 31017018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.